A. Humberstone

发表

Original research article An initial pharmacokinetic study with a Metered Dose Transdermal System® for delivery of the progestogen Nestorone® as a possible future contraceptive ☆

I. Fraser, R. Sitruk-Ware, Narender Kumar, 2007 .

An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.

I. Fraser, R. Sitruk-Ware, Narender Kumar, 2007, Contraception.

Lipid-based vehicles for the oral delivery of poorly water soluble drugs

W. Charman, William N. Charman, A. Humberstone, 1997 .

A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions.

C. Porter, M. Scanlon, W. Charman, 1995, Journal of pharmaceutical and biomedical analysis.

Safety and Efficacy of a Testosterone Metered-Dose Transdermal Spray for Treating Decreased Sexual Satisfaction in Premenopausal Women

R. Norman, S. Davis, B. Stuckey, 2008, Annals of Internal Medicine.

SPL7013 Gel (VivaGel®) Retains Potent HIV-1 and HSV-2 Inhibitory Activity following Vaginal Administration in Humans

T. Spelman, J. Paull, T. Moench, 2011, PloS one.

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

R. Price, J. McCaw, J. Simpson, 2012, Malaria Journal.

Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

F. Petraglia, A. Al-Hendy, E. Stewart, 2022, The Lancet.

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration.

J. Donnez, O. Donnez, E. Loumaye, 2021, Journal of clinical medicine.

Effect of altered serum lipid concentrations on the IC50 of halofantrine against Plasmodium falciparum.

A. Cowman, W. Charman, A. Humberstone, 1998, Journal of pharmaceutical sciences.

Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine

G. Edwards, C. Porter, W. Charman, 1998 .

A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.

C. Porter, W. Charman, C J Porter, 1996, Journal of pharmaceutical sciences.

Lymphatic transport of halofantrine in the conscious rat when administered as either the free base or the hydrochloride salt: effect of lipid class and lipid vehicle dispersion.

C. Porter, S. Charman, W. Charman, 1996, Journal of pharmaceutical sciences.

A Pilot Randomised Trial of Induced Blood-Stage Plasmodium falciparum Infections in Healthy Volunteers for Testing Efficacy of New Antimalarial Drugs

J. McCarthy, P. O’Rourke, S. Elliott, 2011, PloS one.

Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state.

G. Edwards, C. Porter, W. Charman, 1998, Journal of pharmaceutical sciences.

Long term treatment of endometriosis associated pain (EAP) with linzagolix: efficacy and safety after 12 months of treatment

Robert N. Taylor, J. Gotteland, E. Loumaye, 2019, Fertility and Sterility.

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial.

R. Norman, S. Davis, B. Stuckey, 2008, Annals of internal medicine.

Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials.

H. Tournaye, J. Donnez, P. Pierzyński, 2021, Human reproduction.

Application site affects the pharmacokinetics of topical testosterone applied to the axilla compared with the inner arm.

S. Davis, A. Evans, A. Humberstone, 2014, Clinical therapeutics.

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration

J. Donnez, O. Donnez, E. Loumaye, 2021, Journal of clinical medicine.